Advicenne SA
PAR:ALDVI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Advicenne SA
PAR:ALDVI
|
FR |
|
American Superconductor Corp
NASDAQ:AMSC
|
US |
|
L
|
London City Equities Ltd
ASX:LCE
|
AU |
|
Sony Group Corp
TSE:6758
|
JP |
|
T
|
TiumBio Co Ltd
KOSDAQ:321550
|
KR |
|
Astrana Health Inc
NASDAQ:ASTH
|
US |
|
C
|
Castellum Inc
AMEX:CTM
|
US |
|
D
|
Daishin Securities Co Ltd
KRX:003540
|
KR |
|
Dalaroo Metals Ltd
ASX:DAL
|
AU |
|
C
|
Comprehensive Healthcare Systems Inc
XTSX:CHS
|
CA |
|
Bonesupport Holding AB
OTC:BOEUF
|
SE |
|
Erdene Resource Development Corp
TSX:ERD
|
CA |
|
Donnelley Financial Solutions Inc
NYSE:DFIN
|
US |
|
G
|
Golden Arrow Resources Corp
OTC:GARWF
|
CA |
|
Vulcan Materials Co
NYSE:VMC
|
US |
Bankruptcy Probability
Advicenne SA's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Advicenne SA Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| FR |
|
Advicenne SA
PAR:ALDVI
|
9.2m EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.2T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
620.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
OTC:RHHBF
|
382.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
370B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
241.2B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
195.6B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
289.1B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.2T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
170.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
124.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Advicenne SA's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Advicenne SA has total debt of 19m EUR. This includes both short-term (0 EUR) and long-term (19m EUR) debt.
You can find a full breakdown on its Balance Sheet.